-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On OS Therapies with Buy Rating, Announces Price Target of $7

Benzinga·07/09/2026 13:54:11
Listen to the news
Roth Capital analyst Adam Walsh initiates coverage on OS Therapies (AMEX:OSTX) with a Buy rating and announces Price Target of $7.